Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA)

CUSIP: G52694109

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / CLASS A COMMON STOCK
Shares outstanding
45,862,839
Total 13F shares
38,910,834
Share change
-789,194
Total reported value
$769,756,202
Put/Call ratio
103%
Price per share
$19.78
Number of holders
156
Value change
-$20,642,445
Number of buys
73
Number of sells
91

Security key

G52694109

Report period

Q4 2024

Institutions

156

Top holders

10

Top shareholders of KNSA - Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13F
Company
8.3%
3,817,256
$95,393,228 30 Sep 2024
13F
VANGUARD GROUP INC
13F
Company
7.2%
3,298,256
$82,423,418 30 Sep 2024
13F
Fairmount Funds Management LLC
13F
Company
7%
3,204,841
$80,088,977 30 Sep 2024
13F
BRAIDWELL LP
13F
Company
6.3%
2,894,513
$72,333,880 30 Sep 2024
13F
BAKER BROS. ADVISORS LP
13F
Company
6.1%
2,818,323
$70,429,892 30 Sep 2024
13F
Rubric Capital Management LP
13F
Company
5.3%
2,419,103
$60,453,384 30 Sep 2024
13F
HHLR ADVISORS, LTD.
13F
Company
3.5%
1,582,635
$39,550,049 30 Sep 2024
13F
Pictet Asset Management Holding SA
13F
Company
2.6%
1,207,749
$30,181,648 30 Sep 2024
13F
MORGAN STANLEY
13F
Company
2.2%
1,025,471
$25,626,521 30 Sep 2024
13F
Parkman Healthcare Partners LLC
13F
Company
1.6%
755,244
$18,873,548 30 Sep 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.6%
742,307
$18,550,286 30 Sep 2024
13F
Nuveen Asset Management, LLC
13F
Company
1.6%
741,251
$18,523,863 30 Sep 2024
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
1.6%
730,943
$18,266,266 30 Sep 2024
13F
STATE STREET CORP
13F
Company
1.5%
704,712
$17,610,753 30 Sep 2024
13F
FMR LLC
13F
Company
1.5%
696,810
$17,413,290 30 Sep 2024
13F
RICE HALL JAMES & ASSOCIATES, LLC
13F
Company
1.4%
649,630
$16,234,254 30 Sep 2024
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
1.4%
628,609
$15,708,939 30 Sep 2024
13F
ArrowMark Colorado Holdings LLC
13F
Company
1.2%
531,286
$13,276,837 30 Sep 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.1%
516,526
$12,907,985 30 Sep 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
1.1%
508,373
$12,704,241 30 Sep 2024
13F
Granahan Investment Management, LLC
13F
Company
1.1%
507,369
$12,679,151 30 Sep 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
482,976
$12,069,569 30 Sep 2024
13F
ADAR1 Capital Management, LLC
13F
Company
0.95%
436,668
$10,912,333 30 Sep 2024
13F
Qube Research & Technologies Ltd
13F
Company
0.85%
388,356
$9,705,016 30 Sep 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.75%
345,092
$8,623,849 30 Sep 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
0.71%
324,064
$8,098,359 30 Sep 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.7%
320,997
$8,021,715 30 Sep 2024
13F
Soleus Capital Management, L.P.
13F
Company
0.66%
302,500
$7,559,475 30 Sep 2024
13F
NORTHERN TRUST CORP
13F
Company
0.56%
255,206
$6,377,598 30 Sep 2024
13F
PEREGRINE CAPITAL MANAGEMENT LLC
13F
Company
0.52%
239,682
$5,989,653 30 Sep 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.46%
211,118
$5,275,840 30 Sep 2024
13F
OBERWEIS ASSET MANAGEMENT INC/
13F
Company
0.44%
201,000
$5,022,990 30 Sep 2024
13F
ESSEX INVESTMENT MANAGEMENT CO LLC
13F
Company
0.44%
200,516
$5,010,895 30 Sep 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.44%
199,973
$4,997,325 30 Sep 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.43%
198,413
$4,958,341 30 Sep 2024
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
0.43%
195,852
$4,894,341 30 Sep 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.42%
192,926
$4,821,221 30 Sep 2024
13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC
13F
Company
0.41%
189,986
$4,747,750 30 Sep 2024
13F
NORDEA INVESTMENT MANAGEMENT AB
13F
Company
0.41%
186,626
$4,708,575 30 Sep 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.4%
184,169
$4,602,384 30 Sep 2024
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.38%
175,321
$4,381,272 30 Sep 2024
13F
CASTLEARK MANAGEMENT LLC
13F
Company
0.36%
167,200
$4,178,328 30 Sep 2024
13F
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP
13F
Company
0.35%
161,643
$4,039,459 30 Sep 2024
13F
Trexquant Investment LP
13F
Company
0.34%
155,192
$3,878,248 30 Sep 2024
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.26%
118,720
$2,966,813 30 Sep 2024
13F
Linden Thomas Advisory Services, LLC
13F
Company
0.26%
117,710
$2,941,573 30 Sep 2024
13F
STATE OF WISCONSIN INVESTMENT BOARD
13F
Company
0.25%
114,756
$2,867,752 30 Sep 2024
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.23%
106,219
$2,649,000 30 Sep 2024
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.22%
100,001
$2,499,025 30 Sep 2024
13F
Bank of New York Mellon Corp
13F
Company
0.2%
91,669
$2,290,808 30 Sep 2024
13F

Institutional Holders of Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA) as of Q4 2024

As of 31 Dec 2024, Kiniksa Pharmaceuticals International, plc - CLASS A COMMON STOCK (KNSA) was held by 156 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,910,834 shares. The largest 10 holders included BlackRock, Inc., BRAIDWELL LP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Rubric Capital Management LP, Fairmount Funds Management LLC, HHLR ADVISORS, LTD., MORGAN STANLEY, Pictet Asset Management Holding SA, and Nuveen Asset Management, LLC. This page lists 157 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders
172
Q4 2024 holders
156
Holder diff
-16
Investor Q3 2024 Shares Q4 2024 Shares Share Diff Share Chg % Q3 2024 Value $ Q4 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .